Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study

Leukemia. 2023 Aug;37(8):1745-1749. doi: 10.1038/s41375-023-01943-8. Epub 2023 Jun 23.

Kirsi Manz¹, Jeanette Bahr², Till Ittermann³, Konstanze Döhner^{4

5}, Steffen Koschmieder^{4

6}, Tim H Brümmendorf^{4

6}, Martin Griesshammer^{4

7}, Matthias Nauck^{8

9}, Henry Völzke^{3

9}, Florian H Heidel^{10

11}

¹ Institut für Community Medicine - Abteilung Versorgungsepidemiologie und Community Health, Universitätsmedizin Greifswald, Greifswald, Germany.
² Innere Medizin C, Universitätsmedizin Greifswald, Greifswald, Germany.
³ Institut für Community Medicine - Abteilung SHIP-KEF, Universitätsmedizin Greifswald, Greifswald, Germany.
⁴ German MPN Study Group, GSG-MPN, Germany.
⁵ Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany.
⁶ Innere Medizin IV, RWTH Aachen, Aachen, Germany.
⁷ Mühlenkreisklinikum Minden, Universitätsklinikum Bochum, Minden, Germany.
⁸ Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
⁹ DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany.
¹⁰ Innere Medizin C, Universitätsmedizin Greifswald, Greifswald, Germany. [email protected].
¹¹ German MPN Study Group, GSG-MPN, Germany. [email protected].

No abstract available

Publication types